BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30665423)

  • 1. The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population.
    Jalkh N; Corbani S; Haidar Z; Hamdan N; Farah E; Abou Ghoch J; Ghosn R; Salem N; Fawaz A; Djambas Khayat C; Rajab M; Mourani C; Moukarzel A; Rassi S; Gerbaka B; Mansour H; Baassiri M; Dagher R; Breich D; Mégarbané A; Desvignes JP; Delague V; Mehawej C; Chouery E
    BMC Med Genomics; 2019 Jan; 12(1):11. PubMed ID: 30665423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
    Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L
    Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from additional research analyses of unsolved clinical exome cases.
    Eldomery MK; Coban-Akdemir Z; Harel T; Rosenfeld JA; Gambin T; Stray-Pedersen A; Küry S; Mercier S; Lessel D; Denecke J; Wiszniewski W; Penney S; Liu P; Bi W; Lalani SR; Schaaf CP; Wangler MF; Bacino CA; Lewis RA; Potocki L; Graham BH; Belmont JW; Scaglia F; Orange JS; Jhangiani SN; Chiang T; Doddapaneni H; Hu J; Muzny DM; Xia F; Beaudet AL; Boerwinkle E; Eng CM; Plon SE; Sutton VR; Gibbs RA; Posey JE; Yang Y; Lupski JR
    Genome Med; 2017 Mar; 9(1):26. PubMed ID: 28327206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
    Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
    Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reanalysis of exome sequencing data reveals a treatable neurometabolic origin in two previously undiagnosed siblings with neurodevelopmental disorder.
    Susgun S; Kesim Y; Khalilov D; Sirin NG; Gezegen H; Salman B; Yucesan E; Gokcay G; Korbeyli HK; Balci MC; Iseri SAU; Baykan B; Bebek N
    Neurol Sci; 2023 Jul; 44(7):2527-2540. PubMed ID: 36849695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
    Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
    Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
    Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
    Front Immunol; 2022; 13():906328. PubMed ID: 35874679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers.
    Wenger AM; Guturu H; Bernstein JA; Bejerano G
    Genet Med; 2017 Feb; 19(2):209-214. PubMed ID: 27441994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UTILIZATION OF WHOLE EXOME SEQUENCING IN DIAGNOSTICS OF GENETIC DISEASE: RABIN MEDICAL CENTER'S EXPERIENCE].
    Cohen L; Orenstein N; Weisz-Hubshman M; Bazak L; Davidov B; Reinstein E; Tzur S; Behar D; Smirin-Yosef P; Salmon-Divon M; Gross A; Shohat M; Basel-Vanagaite L
    Harefuah; 2017 Apr; 156(4):212-216. PubMed ID: 28551919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
    Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
    JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
    Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
    Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders.
    Marinakis NM; Svingou M; Veltra D; Kekou K; Sofocleous C; Tilemis FN; Kosma K; Tsoutsou E; Fryssira H; Traeger-Synodinos J
    Am J Med Genet A; 2021 Aug; 185(8):2561-2571. PubMed ID: 34008892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of next generation sequencing in pediatric practice in Lebanon. A Study on 213 cases.
    Nair P; Sabbagh S; Mansour H; Fawaz A; Hmaimess G; Noun P; Dagher R; Megarbane H; Hana S; Alame S; Lamaa M; Hasbini D; Farah R; Rajab M; Stora S; El-Tourjuman O; Abou Jaoude P; Chalouhi G; Sayad R; Gillart AC; Al-Ali M; Delague V; El-Hayek S; Mégarbané A
    Mol Genet Genomic Med; 2018 Nov; 6(6):1041-1052. PubMed ID: 30293248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.
    Fokstuen S; Makrythanasis P; Hammar E; Guipponi M; Ranza E; Varvagiannis K; Santoni FA; Albarca-Aguilera M; Poleggi ME; Couchepin F; Brockmann C; Mauron A; Hurst SA; Moret C; Gehrig C; Vannier A; Bevillard J; Araud T; Gimelli S; Stathaki E; Paoloni-Giacobino A; Bottani A; Sloan-Béna F; Sizonenko LD; Mostafavi M; Hamamy H; Nouspikel T; Blouin JL; Antonarakis SE
    Hum Genomics; 2016 Jun; 10(1):24. PubMed ID: 27353043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.